Ledipasvir/Sofosbuvir
신기능 저하

신기능 저하

국내허가사항

투석을 받는 말기 신장 질환(ESRD)을 포함하여 신장애 정도에 관계없이 이 약의 용량조절은 요구되지 않는다.

Mild, moderate, or severe renal impairment

No dose adjustment recommended

Severe with comorbid decompensated cirrhosis

No safety data are available

Severe (estimated GFR < 30 mL/min/1.73 m(2)) with HCV Genotype 1, not on dialysis)

No adjustment necessary although increased exposure was observed

End-Stage Renal Disease (ESRD) on hemodialysis

No adjustment recommended

ESRD on hemodialysis with comorbid decompensated cirrhosis

No safety data are available